Studies have shown that hepatic deficiency in PPARα can impair the ability of the liver to utilize fatty acids, resulting in lipid deposition (Benhamed et al., 2016), whereas its activation can enhance the expression of fatty acid oxidation genes and reduce steatosis (Zhu and Zhao, 2017). The gene discussed is PPARA; the disease is steatosis.